Connect with us

Neck Pain

Global Botulinum Toxin Market Will Reach $ 7.9 Billion By 2026

Published

on

Global Botulinum Toxin Market Will Reach $ 7.9 Billion By 2026

FACTS AT A GLANCE
Edition: 19; Published: April 2021
Executive engagements: 702
Company: 28 – Players Covered include AbbVie; Daewoong Pharmaceutical Co., Ltd .; HUGEL-Pharma; Ipsen Group; Medy-Tox Inc .; Merz Pharma GmbH & Co. KGaA; Metabiologics, Inc .; Revance Therapeutics, Inc .; US WorldMeds and others.
Coverage: All major regions and key segments
Segments: Product (Type A, Type B); Application (therapeutics, aesthetics); End use (specialty and dermatology clinics, hospitals and clinics, other end uses)
Geographies: World; United States; Canada; Japan; China; Europe; France; Germany; Italy; UNITED KINGDOM; Spain; Russia; the rest of Europe; Asia Pacific; Australia; India; South Korea; the rest of Asia Pacific; Latin America; Rest of the world.

Free Project Preview – This is an ongoing global program. Check out our research program before making a purchase decision. We offer free access to qualified executives in the areas of strategy, business development, sales and marketing as well as product management at selected companies. Previews provide insider access to business trends; competitive brands; Domain expert profiles; and market data templates and much more. You can also create your own bespoke report using our MarketGlass ™ platform, which offers thousands of bytes of data, without the need to purchase our report. Registration preview

ABSTRACT-

Reaching Global Botulinum Toxin Market $ 7.9 billion by 2026
Botulinum toxin, a neurotoxin produced by the bacterium Clostridium botulinum, is able to inhibit the release of acetylcholine, which leads to muscle relaxation. Manufactured under controlled laboratory conditions and given in extremely small therapeutic doses, BTX is given intravenously only to the affected area. The growth on the world market is driven by the growing demand in medical-therapeutic and cosmetic applications. The growing acceptance of injectable facial injections such as BTX for facial aesthetics in adults and the approval of therapeutic BTX for the treatment of an expanded range of indications are expected to fuel market expansion. The constant development and introduction of new products to improve aesthetics and the growing demand for minimally invasive treatments in cosmetics and therapeutic applications are fueling market demand. In the field of neuromuscular therapeutics, the use of botulinum toxin is being driven by the increasing incidence of movement-related disorders and the growing number of patients with muscle cramps. In addition, new clinical indications of botulinum toxin such as the treatment of nystagmus, stridor, palatal myoclonus, scoliosis, co-convulsions after lesions of the brachial plexus (birth-related) and gait freeze (Parkinson’s) have helped to further strengthen growth in this area.

In the midst of the COVID-19 crisis, the global botulinum toxin market is on the rise. estimated $ 4.9 billion in 2020 is expected to reach a revised size of $ 7.9 billion until 2026 with a CAGR of 8.2% in the analysis period. Type A, one of the segments analyzed in the report, is expected to have 8.2% CAGR and reach a record $ 8.5 billion until the end of the analysis period. After a thorough analysis of the business impact of the pandemic and its triggered economic crisis, the Type B segment growth will be adjusted to a revised CAGR of 6.9% for the next 7 year period. Botulinum toxin type A is used in the treatment of movement disorders, vocal cord dysfunction, and obesity, and is also used as a medical aid in stomach cancer. The growth of botulinum toxin type A is being driven by its increasing use in the treatment of muscle spasms in cerebral palsy and neurogenic bladder diseases in children. Type B is used for various muscle-related diseases. Botulinum neurotoxin type B was approved by the FDA in 2000 for the treatment of adults with cervical dystonia to reduce the severity of abnormal head posture and neck pain associated with cervical dystonia.

The US market is estimated at $ 3.1 billion in 2021, while China is expected to reach $ 665 million by 2026
The US botulinum toxin market is estimated at $ 3.1 billion in 2021. China, the second largest economy in the world, is expected to reach a market size of $ 665 million by 2026 with a CAGR of 14.8% in the analysis period. Other notable geographic markets include Japan and Canada, which will grow by 8.1% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow about 9.1% CAGR. The United States represents the largest regional market, which is mainly driven by the growing approval of new therapeutic indications. The increasing focus on improving appearance, rising disposable incomes and the resulting increase in demand for cosmetic procedures are also spurring growth. The increasing demand for non-invasive or minimally invasive aesthetic treatments is also contributing to the growth of the botox market in the United States. Europe also offers attractive opportunities for the botox market due to the presence of a large number of cosmetic manufacturers. The rapid improvement in socio-economic conditions and the increase in medical tourism, particularly in Asian countries, offer favorable prospects for botulinum toxin in Asia Pacific Region. More

MarketGlass ™ platform
Our MarketGlass ™ platform is a free, full-stack knowledge center that can be customized to meet the intelligence needs of today’s busy business leaders! This influencer-controlled interactive research platform is the heart of our primary research activities and is based on the unique perspectives of the participating executives worldwide. Features include – enterprise-wide peer-to-peer collaboration; previews of research programs relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke reporting; Monitor market trends; competitive brands; Create and publish blogs and podcasts with our primary and secondary content; Track domain events worldwide; and much more. Client companies have complete insider access to the project data stacks. Currently used by over 67,000 domain experts worldwide.

Our platform is free for qualified executives and accessible through our website www.StrategyR.com or through our recently released mobile application for iOS or Android

About Global Industry Analysts, Inc. & StrategyR ™
Global Industry Analysts, Inc. (www.strategyr.com) is a renowned market research publisher and the world’s only influencer-driven market research company. GIA proudly serves more than 42,000 customers from 36 countries and has been known for accurate market and industry forecasting for over 33 years.

CONTACTS:
Zak Ali
Director, corporate communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
E-mail: [email protected]

LEFT
Join our panel of experts
https://www.strategyr.com/Panelist.asp

Connect with us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow us on Twitter
https://twitter.com/marketbytes

Journalists & media
[email protected]

SOURCE Global Industry Analysts, Inc.

We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.

Continue Reading

Neck Pain

Re: Chronic Pain: Management focuses on the individual, not the pain.

Published

on

Dear Editor

Chronic pain management focuses on the individual, not the pain.

I am very pleased with the review by Kang and colleagues [1]. I write as a spinal pain specialist whose patients had an average episode duration of pain pain of 2.5 years [2] for low back pain and 1.3 years for neck pain [3]. These studies confirm that Kang et. al. noted the significant extent of spinal and extraspinal pain, sleep disturbance, and psychological distress. I also recognize the ‘heartsinks’ who have seen many consultants for a variety of complaints, and those with hypersensitivity. I do accept that some patients need further investigations, but it can be done in a way that does not cause further anxiety. To ensure that intensive rehabilitation is not contraindicated. By showing a genuine interest in the family, job and interests of the individual, you can begin to build confidence and hope for the clinical path being recommended.

The review ignores trauma’s effects on some people, causing their pain to begin, and for others, a major factor. Thirteen percent of patients with neck pain who presented to my clinics had a traumatic origin with a missed break and significant psychological comorbidity. Subsequently, it became clear that post-traumatic distress (PTPD), [a term used because post-traumatic stress may require specialist knowledge for diagnosis] can be present in rheumatological practices [4] and with the increasing influx of refugees in the UK [5], more patients are being diagnosed with PTPD. This can have major effects on families [5]. PTPD is commonly seen in medicolegal situations where accidents have caused major destruction to the lives of individuals and their families, including divorce [6]; and is often associated mood disturbances [6].

Kang et. al. correctly mention that sleep disorders are important in the management chronic pain [1], however, two important aspects of a’sleep story’ must be identified. It is important to ask the individual what they are thinking about when they lie awake in bed at night. This may provide clues as to social or family stress. Second, you should ask about their nightmares and dreams, especially if they are unpleasant. These often involve reliving trauma or accidents. When asked about nightmares, people who deny any unpleasant memories during direct questioning may reveal clues. The presence of PTPD can be important because it opens up therapeutic opportunities with psychological support and medications.

My experience in rehabilitation medicine over the years has taught me that to fully assist our disadvantaged clients, social issues must be resolved before psychological issues, and psychological issues must be resolved before physical issues!

References

1. Kang Y et. al., Chronic Pain: Definitions and Diagnosis. BMJ (Clinical Research ed. ), 2023. 381: p. e076036.

2. Frank A. et al. A cross-sectional study of the clinical and psychosocial features of low back injury and the resulting work handicap: Use of the Quebec Task Force Classification. Int J Clin Pract, 2000; 54(10) p. 639-644.

3. Frank A, De Souza L and Frank C. Neck Pain and Disability: A Cross-sectional Survey of the Demographic and Clinical Characteristics of Neck Pain Seen in a Rheumatology Clinic. Int J Clin Pract 2005; 59(doi: 10.1111/j.1742-1241.2004.00237.x): p. 173-182.

4. McCarthy J. and Frank A. Posttraumatic psychological distress can present in rheumatology. BMJ 2002. 325(27 July): p. 221-221.

5. Frank A. Refugee status: a yellow-flag in managing back pain. BMJ 2007;334(13 Jan): p.58-58.

6. Frank A. Psychiatric effects of road traffic accidents: often disabling, and not recognised (letter). BMJ 1993, 307(13th Nov): p.1283.

Continue Reading

Neck Pain

Landmark Trial: Opioids No Better Than Placebo for Back Pain

Published

on

The first randomized controlled study testing the efficacy of a short course opioids for acute nonspecific neck/low back pain suggests that opioids do not relieve acute neck or low back pain in the short-term and can lead to worse outcomes over the long-term.

After 6 weeks there was no significant difference between the pain scores of patients taking opioids and those who took a placebo. After one year, the pain scores of patients who received placebos were slightly lower. After 1 year, opioid users were also at a higher risk of opioid abuse.

Senior author Christine Lin, Ph.D., from the University of Sydney told Medscape Medical News that this is a “landmark trial” with “practice changing” results.

Lin explained that “we did not have any good evidence before this trial on whether opioids are effective for acute neck or low back pain, but opioids are one of the most commonly prescribed medicines for these conditions.”

Lin stated that based on these results “opioids shouldn’t be recommended at any time for acute neck and low back pain,”

The results of the OPAL study have been published online in The Lancet on June 28.

Rigorous Test

The trial was conducted at 157 primary care and emergency departments in Australia, with 347 adults who experienced low back pain or neck pain for 12 weeks or less.

They were randomly allocated (1:1) to receive guideline-recommended care (reassurance and advice to stay active) plus an opioid (oxycodone up to 20 mg daily) or identical placebo for up to 6 weeks. Naloxone is given to prevent opioid-induced constipation, and to improve blinding.

The primary outcome was the pain severity at six weeks, as measured by the pain severity subscale (10-point scale) of the Brief Pain Inventory.

After 6 weeks of opioid therapy, there was no difference between placebo and opioid therapy in terms of pain relief or functional improvement.

The mean pain score was 2.78 for the opioid group at 6 weeks, compared to 2.25 for the placebo group. (Adjusted median difference, 0.53, 95% CI -0.00 – 1.07, P=.051). At 1 year, the mean pain scores of the placebo group were lower than those of the opioid group (1.8 and 2.4).

The risk of opioid misuse was doubled at 1 year for patients randomly assigned to receive opioid therapy during 6 weeks as compared to those randomly assigned to receive placebo during 6 weeks.

At 1 year, the Current Opioid Use Measure (COMM), a scale that measures current drug-related behavior, indicated that 24 (20%) patients from 123 patients who received opioids, were at risk for misuse. This was compared to 13 (10%) patients from 128 patients in a placebo group ( p =.049). The COMM is a widely-used measure of current aberrant drug related behavior among chronic pain patients who are prescribed opioid therapy.

Results Raise “Serious Questions”

Lin told Medscape Medical News that “I think the findings of the research will need to be distributed to doctors and patients so they receive the latest evidence on opioids.”

“We must reassure doctors and their patients that the majority of people with acute neck and low back pain recover well over time (normally within 6 weeks). Therefore, management is simple – stay active, avoid bed rest and, if needed, use a heat pack to relieve short term pain. Consider anti-inflammatory drugs if drugs are needed,” Lin added.

The authors of the linked comment state that the OPAL trial raises serious questions regarding the use of opioids for acute neck and low back pain.

Mark Sullivan, MD PhD, and Jane Ballantyne MD, from the University of Washington in Seattle, note that clinical guidelines recommend opioids to patients with acute neck and back pain when other drugs fail or are contraindicated.

As many as two thirds of patients may receive an opioid for back or neck pain. Sullivan and Ballantyne say that it is time to reexamine these guidelines.

The National Health and Medical Research Council (NHMRC), the University of Sydney Faculty of Medicine and Health (University of Sydney Faculty of Medicine and Health) and SafeWork SA funded the OPAL study. The authors of the study have not disclosed any relevant financial relationships. Sullivan and Ballantyne have served as board members of Physicians for Responsible Opioid Prescribing (unpaid), and paid consultants for opioid litigation.

Lancet. Online published June 28, 2023. Abstract

Join us on Facebook or Twitter for more Medscape Neurology News.

Continue Reading

Neck Pain

‘I tried acupuncture for back and neck pain even though I’m afraid of needles–and it’s literally the only thing that’s ever worked’

Published

on

To view this content, you must be logged-in as a subscriber.

4 WEEKS

$10

UNLIMITED

DIGITAL ACCESS

4 WEEKS


52 WEEKS

$130

UNLIMITED

DIGITAL ACCESS

52 WEEKS OF WORK


Day Pass

$2.99

UNLIMITED

DIGITAL ACCESS

FOR 24 HOURS

All plans include full website access and exclusive online extras.

Plans available in both print and digital formats


ALREADY a print subscriber?


Continue Reading
How Often Should You Exercise to Maintain Lower Back Health?
Exercise5 months ago

How Often Should You Exercise to Maintain Lower Back Health?

What Are the Top 10 Exercises for Sciatica Pain Relief?
spanish6 months ago

What Are the Top 10 Exercises for Sciatica Pain Relief?

What Are the Top 10 Exercises for Sciatica Pain Relief?
Sciatica6 months ago

What Are the Top 10 Exercises for Sciatica Pain Relief?

How Does Proper Hydration Reduce Muscle Pain Naturally?
spanish6 months ago

How Does Proper Hydration Reduce Muscle Pain Naturally?

How Does Proper Hydration Reduce Muscle Pain Naturally?
Sciatica6 months ago

How Does Proper Hydration Reduce Muscle Pain Naturally?

How Does Stretching Help in Easing Sciatica Discomfort?
spanish1 year ago

How Does Stretching Help in Easing Sciatica Discomfort?

Are Mesh Back Chairs Better for Sciatica Pain Relief?
spanish1 year ago

Are Mesh Back Chairs Better for Sciatica Pain Relief?

Are Mesh Back Chairs Better for Sciatica Pain Relief?
Sciatica1 year ago

Are Mesh Back Chairs Better for Sciatica Pain Relief?

How Does Stretching Help in Easing Sciatica Discomfort?
Sciatica1 year ago

How Does Stretching Help in Easing Sciatica Discomfort?

What Are the Top 10 Herbal Remedies for Natural Muscle Pain Relief?
Uncategorized1 year ago

What Are the Top 10 Herbal Remedies for Natural Muscle Pain Relief?

How Does Regular Exercise Help Alleviate Lower Back Pain?
Back Pain1 year ago

How Does Regular Exercise Help Alleviate Lower Back Pain?

How Does Aging Contribute to Chronic Lower Back Pain?
Back Pain1 year ago

How Does Aging Contribute to Chronic Lower Back Pain?

¿Desaparecerá el entumecimiento de los pies con ciática?
spanish1 year ago

¿Desaparecerá el entumecimiento de los pies con ciática?

How Effective Are Herbal Supplements for Alleviating Sciatica Pain?
spanish1 year ago

How Effective Are Herbal Supplements for Alleviating Sciatica Pain?

How Does Heat Therapy Provide Natural Relief From Muscle Pain?
Back Pain1 year ago

How Does Heat Therapy Provide Natural Relief From Muscle Pain?

How Effective Are Herbal Supplements for Alleviating Sciatica Pain?
Sciatica1 year ago

How Effective Are Herbal Supplements for Alleviating Sciatica Pain?

Shoulder Pain2 years ago

If You’re Not Sleeping In These Two Positions, A Chiropractor Says You Need To Change That | Sleepopolis

Neck Pain2 years ago

Re: Chronic Pain: Management focuses on the individual, not the pain.

Neck Pain2 years ago

Landmark Trial: Opioids No Better Than Placebo for Back Pain

Neck Pain2 years ago

‘I tried acupuncture for back and neck pain even though I’m afraid of needles–and it’s literally the only thing that’s ever worked’

The Pain Tape Game: Does KT Tape Help With Sciatica?
spanish2 years ago

The Pain Tape Game: Does KT Tape Help With Sciatica?

Neck Pain2 years ago

How to manage sleep neck discomfort

Neck Pain2 years ago

5 best pillows for neck support: Get the right support to sleep soundly

Neck Pain2 years ago

ABC Radio National

Neck Pain2 years ago

You can get relief from Cervical Spondylosis by using these home remedies. THESE Home Remedies can help you

The Pain Tape Game: Does KT Tape Help With Sciatica?
Shoulder Pain2 years ago

Crack! Crunch! Chiropractic videos help chiropractors find the correct spot.

The Pain Tape Game: Does KT Tape Help With Sciatica?
Sciatica2 years ago

The Pain Tape Game: Does KT Tape Help With Sciatica?

Neck Pain2 years ago

The text neck syndrome is becoming more common among young people

¿Desaparecerá el entumecimiento de los pies con ciática?
Sciatica2 years ago

Will Foot Numbness with Sciatica Go Away?

Neck Pain2 years ago

Back and neck pain relief – Opioids similar to placebo

Trending

American Chiropractors Directory and News